BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18752050)

  • 21. Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia.
    Dietrich W; Haitel A; Holzer G; Huber JC; Kolbus A; Tschugguel W
    J Soc Gynecol Investig; 2006 Oct; 13(7):512-7. PubMed ID: 16990033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
    Abul-Hajj YJ
    Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells.
    Honorat M; Mesnier A; Vendrell J; Guitton J; Bieche I; Lidereau R; Kruh GD; Dumontet C; Cohen P; Payen L
    Endocr Relat Cancer; 2008 Mar; 15(1):125-38. PubMed ID: 18310281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data.
    Townsend PA; Dublin E; Hart IR; Kao RH; Hanby AM; Cutress RI; Poulsom R; Ryder K; Barnes DM; Packham G
    J Pathol; 2002 May; 197(1):51-9. PubMed ID: 12081204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia.
    Shaaban AM; O'Neill PA; Davies MP; Sibson R; West CR; Smith PH; Foster CS
    Am J Surg Pathol; 2003 Dec; 27(12):1502-12. PubMed ID: 14657709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women.
    Li Q; Zheng D; Lin H; Zhong F; Liu J; Wu Y; Wang Z; Guan Q; Zhao M; Gao L; Zhao J
    Front Endocrinol (Lausanne); 2021; 12():627903. PubMed ID: 33868168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women.
    Gebhart JB; Rickard DJ; Barrett TJ; Lesnick TG; Webb MJ; Podratz KC; Spelsberg TC
    Am J Obstet Gynecol; 2001 Dec; 185(6):1325-30; discussion 1330-1. PubMed ID: 11744904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer.
    Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
    Gynecol Endocrinol; 2009 Mar; 25(3):183-7. PubMed ID: 19347708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia.
    Nonni A; Zagouri F; Sergentanis TN; Lazaris AC; Patsouris ES; Zografos GC
    Virchows Arch; 2007 Nov; 451(5):893-7. PubMed ID: 17924141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
    Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
    Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.
    Tong D; Schuster E; Seifert M; Czerwenka K; Leodolte S; Zeillinger R
    Breast Cancer Res Treat; 2002 Feb; 71(3):249-55. PubMed ID: 12002343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of estrogen receptor-alpha and Ki67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma.
    Ding SL; Sheu LF; Yu JC; Yang TL; Chen B; Leu FJ; Shen CY
    J Biomed Sci; 2004; 11(6):911-9. PubMed ID: 15591788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Major Pre- and Postmenopausal Estrogens Play Opposing Roles in Obesity-Driven Mammary Inflammation and Breast Cancer Development.
    Qureshi R; Picon-Ruiz M; Aurrekoetxea-Rodriguez I; Nunes de Paiva V; D'Amico M; Yoon H; Radhakrishnan R; Morata-Tarifa C; Ince T; Lippman ME; Thaller SR; Rodgers SE; Kesmodel S; Vivanco MDM; Slingerland JM
    Cell Metab; 2020 Jun; 31(6):1154-1172.e9. PubMed ID: 32492394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between serum E2 levels and recurrence in premenopausal, ER-positive breast cancer patients: A retrospective study.
    Takuwa H; Saji S; Takada M; Takahara S; Yamauchi A
    Breast Dis; 2018; 37(4):185-190. PubMed ID: 29578459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
    Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
    Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low pulse oxygen saturation in post-menopausal women at high altitude is related to a high serum testosterone/estradiol ratio.
    Gonzales GF; Villena A
    Int J Gynaecol Obstet; 2000 Nov; 71(2):147-54. PubMed ID: 11064012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
    Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
    Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer.
    Masuda N; Iwata H; Rai Y; Anan K; Takeuchi T; Kohno N; Takei H; Yanagita Y; Noguchi S
    Breast Cancer Res Treat; 2011 Apr; 126(2):443-51. PubMed ID: 21221770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.